Balance Sheet Data
Anika Therapeutics, Inc. (ANIK)
$27.55
+0.93 (+3.49%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 159.01 | 184.94 | 98.32 | 94.39 | 86.33 | 174.65 | 192.73 | 212.68 | 234.69 | 258.99 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 20.78 | 23.08 | 24.10 | 29.84 | 34.63 | 34.71 | 38.30 | 42.26 | 46.64 | 51.47 |
| Account Receivables (%) | ||||||||||
| Inventories | 25.13 | 21.99 | 46.21 | 36.01 | 39.77 | 44.22 | 48.80 | 53.85 | 59.42 | 65.57 |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.14 | 3.83 | 8.98 | 7.63 | 9.07 | 8.34 | 9.20 | 10.15 | 11.20 | 12.36 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -4.66 | -2.83 | -1.63 | -5.14 | -7.49 | -5.65 | -6.24 | -6.89 | -7.60 | -8.38 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.